Home / Research / Product codes / LON Medical-device intelligence
LON: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation FDA product code LON: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation. View classification details, related manufacturers, 510(k) clearances, and recall records.
Classification details
Product code LON
FDA device name System, Test, Automated, Antimicrobial Susceptibility, Short Incubation
Device class 2
Regulation number 866.1645
Medical specialty Microbiology
Review panel MI The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.
Explore microbiology records → A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.
Record activity in this scope 293 clearance records and 240 recall records in the covered releases, across 22 source company names and 1 product codes. Dated history runs from Aug 1, 1986 to Nov 4, 2026.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 1 0 April 2026 1 0 May 2026 0 0 June 2026 0 3 July 2026 0 1 August 2026 0 2 September 2026 1 0 October 2026 1 0
Product codes represented All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 533 matching records Device / record Company in FDA record Source Source date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFUROXIME (GN) 1-64 UG/ML K062207 · LONBecton, Dickinson & CO 510(k) Sep 13, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - MOXIFLOXACIN (STREP) 0.0625 - 8UG/ML K062206 · LONBecton, Dickinson & CO 510(k) Sep 8, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-PIPERACILLIN-TAZOBACTAM (GP) 1/4-128/4 UG/ML K061869 · LONBecton, Dickinson & CO 510(k) Aug 18, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CEFAZOLIN (GN) 0.5-32 UG/ML K061867 · LONBecton, Dickinson & CO 510(k) Aug 10, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-AMOXICILLIN-CLAVULANATE(GP) 0.25/0.12 -32/16 UG/ML K061673 · LONBecton, Dickinson & CO 510(k) Jul 28, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-AMOXICILLIN-CLAVULANATE (GN) 0.5/0.25-32/16 UG/ML, AMPICILLIN-SULBACTAM (GN) 0. K061327 · LONBecton, Dickinson & CO 510(k) Jul 3, 2006FDA decision date VITEK 2 GRAM POSITIVE VRSA SCREEN K061347 · LONbioMerieux, Inc. 510(k) Jun 20, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - AMPICILLIN (GN) 0.5-32 UG/ML K061355 · LONBecton, Dickinson & CO 510(k) Jun 7, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM FOR USE WITH THE ANTIMICROBIAL AGENT GATIFLOXACIN 0.25-8 UG/ML - GRAM-NEGATIVE K060324 · LONBecton, Dickinson & CO 510(k) May 25, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM CEPHALOTHIN - GN 1 - 64 UG/ML K060558 · LONBecton, Dickinson & CO 510(k) May 11, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM -NITROFURANTOIN (GN) 8-512 UG/ML, TRIMETHOPRIM-SULFAMETHOXAZOLE (GN) K060447 · LONBecton, Dickinson & CO 510(k) Apr 26, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFOXITIN - 0.5-64 UG/ML K060257 · LONBecton, Dickinson & CO 510(k) Apr 14, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - MOXIFLOXACIN-0.125-8 AND CIPROFLOXACIN-0.25 - 4 UG/ML K060217 · LONBecton, Dickinson & CO 510(k) Apr 12, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFEPIME (GN) , CEFTRIAXONE (GN), CEFOTAXIME (GN), 0.5-64 UG/ML K060444 · LONBecton, Dickinson & CO 510(k) Apr 12, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - VANCOMYCIN-GP DETECTION OF VRSA. K060493 · LONBecton, Dickinson & CO 510(k) Mar 29, 2006FDA decision date MICROSCAN SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS WITH VANCOMYCIN (0.25-64 UG/ML) K060312 · LONDade Behring, Inc. 510(k) Mar 23, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - ERYTHROMYCIN-0.0625-8 UG/ML, AND QUINUPRISTIN/DALFOPRISTIN-0.25-4 UG/ML K060218 · LONBecton, Dickinson & CO 510(k) Mar 17, 2006FDA decision date BD PHOENIX AUTOMATED MIRCROBIOLOGY SYSTEM TETRACYCLINE-GN 0.5-16 UG/ML AND GP 0.5-16 UG/ML K060214 · LONBecton, Dickinson & CO 510(k) Mar 9, 2006FDA decision date MICROSCAN SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS WITH ERYTHROMYCIN (0.12-16 UG/ML) K053504 · LONDade Behring, Inc. 510(k) Feb 24, 2006FDA decision date MICROSCAN SYNERGIES PLUS GRAM POSITIVE MIC/COMBO PANELS - AMPICILLIN K060088 · LONDade Behring, Inc. 510(k) Feb 3, 2006FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFOXITIN GP 1-32 G/ML K053241 · LONBecton, Dickinson & CO 510(k) Dec 22, 2005FDA decision date VITEK 2 GRAM POSITIVE CEFOXITIN SCREEN K053097 · LONbioMerieux, Inc. 510(k) Dec 14, 2005FDA decision date VITEK 2 GRAM POSITIVE TELITHROMYCIN FOR STREPTOCOCCUS PNEUMONIAE K053186 · LONbioMerieux, Inc. 510(k) Dec 1, 2005FDA decision date VITEK GRAM POSITIVE SUSCEPTIBILITY DAPTOMYCIN K052656 · LONbioMerieux, Inc. 510(k) Nov 7, 2005FDA decision date SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS K052346 · LONDade Behring, Inc. 510(k) Oct 26, 2005FDA decision date
Manufacturers in these records Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗